DE3578613D1 - Verfahren zur reinigung des influenzavirus. - Google Patents

Verfahren zur reinigung des influenzavirus.

Info

Publication number
DE3578613D1
DE3578613D1 DE8585110012T DE3578613T DE3578613D1 DE 3578613 D1 DE3578613 D1 DE 3578613D1 DE 8585110012 T DE8585110012 T DE 8585110012T DE 3578613 T DE3578613 T DE 3578613T DE 3578613 D1 DE3578613 D1 DE 3578613D1
Authority
DE
Germany
Prior art keywords
influenza virus
cleaning
influence virus
virus
chromatography
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8585110012T
Other languages
German (de)
English (en)
Inventor
Tetsuya Oka
Kunio Ohkuma
Tetsuo Kawahara
Mitsuo Sakoh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemo Sero Therapeutic Research Institute Kaketsuken
Original Assignee
Chemo Sero Therapeutic Research Institute Kaketsuken
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeutic Research Institute Kaketsuken filed Critical Chemo Sero Therapeutic Research Institute Kaketsuken
Application granted granted Critical
Publication of DE3578613D1 publication Critical patent/DE3578613D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151—Methods of production or purification of viral material

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Pulmonology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8585110012T 1984-08-09 1985-08-08 Verfahren zur reinigung des influenzavirus. Expired - Lifetime DE3578613D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59167324A JPS6147186A (ja) 1984-08-09 1984-08-09 インフルエンザウイルスの精製方法

Publications (1)

Publication Number Publication Date
DE3578613D1 true DE3578613D1 (de) 1990-08-16

Family

ID=15847633

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585110012T Expired - Lifetime DE3578613D1 (de) 1984-08-09 1985-08-08 Verfahren zur reinigung des influenzavirus.

Country Status (7)

Country Link
US (1) US4724210A (enExample)
EP (1) EP0171086B1 (enExample)
JP (1) JPS6147186A (enExample)
KR (1) KR920009733B1 (enExample)
AT (1) ATE54468T1 (enExample)
CA (1) CA1251399A (enExample)
DE (1) DE3578613D1 (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5215739A (en) * 1989-04-05 1993-06-01 Toko Yakuhin Kogyo Kabushiki Kaisha Spray gel base and spray gel preparation using thereof
US5158761A (en) * 1989-04-05 1992-10-27 Toko Yakuhin Kogyo Kabushiki Kaisha Spray gel base and spray gel preparation using thereof
FR2667622B1 (fr) * 1990-10-08 1994-10-07 Kaysersberg Sa Montisse lie hydrauliquement et son procede de fabrication.
IT1248075B (it) * 1991-06-18 1995-01-05 Sclavo Spa Processo per la purificazione del virus dell'epatite a (hav), virus cosi` purificato e composizioni vaccinali che lo contengono.
US5447859A (en) * 1993-07-16 1995-09-05 Viagene Method for the purification or removal of retroviruses using sulfated cellulose
EP1010981A1 (de) * 1998-12-18 2000-06-21 Diagor GmbH Konjugate zum Nachweis von Viren und deren Verwendung
JP2002142770A (ja) 2000-11-08 2002-05-21 Dnavec Research Inc 循環系への遺伝子送達用パラミクソウイルスベクター
PL354822A1 (en) * 2002-06-30 2004-01-12 Instytut Immunologii i Terapii Doświadczalnej PANwe Wrocławiu Method of receiving purified bacteriophage preparations and new applications of polysaccharide or its esterificated derivative
AU2004249199B2 (en) * 2003-06-18 2008-07-24 Onyx Pharmaceuticals, Inc. Method for purifying virus
ATE478137T1 (de) * 2003-06-20 2010-09-15 Microbix Biosystems Inc Verbesserungen bei der virusproduktion
CA2544786A1 (en) 2003-11-04 2005-05-12 Dnavec Research Inc. Method for producing gene transferred dendritic cells
EP1916298B1 (en) 2005-06-14 2011-12-28 Dnavec Corporation Methods for producing monoclonal antibodies
US8877187B2 (en) * 2005-07-25 2014-11-04 Avianax, Llc Therapeutic antibodies for treatment and prophylaxis of transmittable viral diseases
US20070065452A1 (en) * 2005-07-25 2007-03-22 Avianax Therapeutic antibodies for treatment and prophylaxis of transmittable viral diseases
EP1808697A1 (en) * 2006-01-13 2007-07-18 Novartis Vaccines and Diagnostics, Inc. Use of an ion exchange matrix for determining the concentration of virus particles and/or virus antigens
JPWO2007083644A1 (ja) 2006-01-17 2009-06-11 ディナベック株式会社 新規タンパク質発現系
US20100297604A1 (en) * 2006-06-09 2010-11-25 Xing-Xiang Li Methods and reagents for virus isolation and detection
EP1878791A1 (en) * 2006-07-11 2008-01-16 Bia Separations D.O.O. Method for influenza virus purification
WO2008007581A1 (en) 2006-07-13 2008-01-17 Dnavec Corporation Non-replicating paramyxoviridae virus vector
WO2008039136A1 (en) * 2006-09-29 2008-04-03 Ge Healthcare Bio-Sciences Ab Separation matrix for viral purification
EP1982727A1 (en) 2007-04-17 2008-10-22 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Method for purification of viral proteins
EP2143794A1 (en) 2007-04-27 2010-01-13 Kyushu University, National University Corporation Viral vector for gene therapy
EP2173866A2 (en) * 2007-06-29 2010-04-14 Avianax, LLC Vaccine production for pathogenic bird viral diseases
JP5389342B2 (ja) * 2007-08-09 2014-01-15 デンカ生研株式会社 吸着担体及び吸着担体の製造方法
JP5716297B2 (ja) 2009-06-25 2015-05-13 Jnc株式会社 クロマトグラフィー用充填剤、その製造方法、およびそれを用いたウイルス用ワクチンの製造方法
BR112012026095A2 (pt) 2010-04-14 2015-09-15 Emd Millipore Corp métodos de produção de estoques de vírus de alta pureza e altos títulos e métodos de uso dos mesmos.
CN104968403A (zh) 2012-09-17 2015-10-07 格雷斯公司 色谱介质和装置
CN105518059B (zh) * 2013-09-02 2019-01-01 捷恩智株式会社 多孔性纤维素粒子的制造方法、多孔性纤维素粒子及色谱法用填充剂
DE102013017014B4 (de) 2013-10-14 2017-03-30 Sartorius Stedim Biotech Gmbh Sulfatierte Cellulosehydrat-Membran, Verfahren zur ihrer Herstellung und Verwendung der Membran als Adsorptionsmembran für die Virenaufreinigung
ES2929099T3 (es) 2014-05-02 2022-11-24 Grace W R & Co Material de soporte funcionalizado y métodos de fabricación y uso de material de soporte funcionalizado
EP2966093A1 (en) 2014-07-07 2016-01-13 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Process for the preparation of magnetic sulfated cellulose particles, magnetic sulfated cellulose particles and their use
PL3302784T3 (pl) 2015-06-05 2022-01-17 W.R. Grace & Co.-Conn. Adsorbentowe środki klarujące do bioprzetwarzania oraz sposoby ich wytwarzania i stosowania
US10626376B2 (en) 2016-11-14 2020-04-21 St. Jude Children's Research Hospital Method for isolating and purifying adeno-associated virus particles using salt
CN106622159B (zh) * 2016-12-22 2019-06-14 苏州楚博生物技术有限公司 用于蛋白药物纯化的亲和层析介质

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL131092C (enExample) *
US3105012A (en) * 1961-10-19 1963-09-24 Parke Davis & Co Antigen products and means for producing the same
BE662899A (enExample) * 1964-04-22
US3547779A (en) * 1968-12-18 1970-12-15 Merck & Co Inc Process for producing purified concentrated influenza virus
SE356735B (enExample) * 1970-12-02 1973-06-04 Svenska Cellulosa Ab
US3842062A (en) * 1972-09-27 1974-10-15 Du Pont Water-soluble complexes of protein and anionic polyelectrolytes such as sodium carboxymethyl cellulose
US3920625A (en) * 1973-06-19 1975-11-18 Kabi Ab Isolation of coagulation factors from biological material using cross linked sulfated, sulfonated carbohydrates
US4160018A (en) * 1973-06-25 1979-07-03 Bjorklund Knut B Stabilized cancer associated polypeptide antigen and preparation thereof
IL49752A (en) * 1975-07-09 1979-07-25 Kabi Ab Compositions having affinity for hepatitis virus and method for hepatitis virus removal or concentration
SE420977B (sv) * 1976-03-18 1981-11-16 Kabi Ab Forfarande for rening och isolering av hepatitvirus for vaccinframstellning
US4181713A (en) * 1978-10-30 1980-01-01 Merck & Co., Inc. Isolation of HBs Ag
DE3014189A1 (de) * 1980-04-14 1981-10-15 Europäisches Laboratorium für Molekularbiologie (EMBL), 6900 Heidelberg Verfahren zur herstellung eines immunogenen membranproteinaggregats von influenza-, parainfluenza- und rhabdo-viren
JPS57136528A (en) * 1981-02-09 1982-08-23 Hayashibara Biochem Lab Inc Preparation of viral vaccine
US4434093A (en) * 1982-07-26 1984-02-28 Ortho Diagnostic Systems Inc. Methods for preparation of HBs Ag free gamma globulins
US4515714A (en) * 1983-03-09 1985-05-07 Juridicial Foundation, The Chemo-Semo-Sero-Therapeutic Research Institute Method for purification of hepatitis B virus surface antigen

Also Published As

Publication number Publication date
EP0171086A3 (en) 1988-01-13
US4724210A (en) 1988-02-09
ATE54468T1 (de) 1990-07-15
KR920009733B1 (ko) 1992-10-22
CA1251399A (en) 1989-03-21
EP0171086B1 (en) 1990-07-11
EP0171086A2 (en) 1986-02-12
KR870001835A (ko) 1987-03-28
JPS6230752B2 (enExample) 1987-07-03
JPS6147186A (ja) 1986-03-07

Similar Documents

Publication Publication Date Title
DE3578613D1 (de) Verfahren zur reinigung des influenzavirus.
DE3578839D1 (de) Verfahren zur reinigung des japanischen enzephalitisvirus.
ATE50594T1 (de) Verfahren zur reinigung des tollwutvirus.
DK481889D0 (da) Fremgangsmaade til adskillelse af stereoisomere i flerfase- og ekstraktive membranreaktorer
ATE45728T1 (de) Verfahren zur herstellung bestimmter enantiomerenpaare von permethrinsaeure-alpha-cyano-3-phenoxy-4-fluor-b nzyl-ester.
PT87920A (pt) Processo de preparacao de inibidores da dopamina-beta-hidroxilase
IT1123928B (it) Processo per preparare benzil esteri sostituiti di acidi ciclopropancarbossilici o acidi fenilacetici
DK154562C (da) Fremgangsmaade til fremstilling af isosorbid-2-acylat
MX7055E (es) Procedimiento enzimatico mejorado de clarificacion de soluciones acuosas de gomas xantanos para mejorar su filtrabilidad
BR8901038A (pt) Processo para isolamento ou purificacao de acidos c14-c24-graxos saturados,preponderantemente metil-ramificados
ATE20071T1 (de) Verfahren zur reinigung von sekretin.
IT1074825B (it) Procedimento per la purificazione di acidi alchilsolfonici
DE3886118D1 (de) Methode zur Reinigung von Interferon.
FI964123A7 (fi) Amidokarboksyylihapon puhdistaminen neste/nesteuutolla
FR2432499A1 (fr) Procede de purification d'amines tertiaires
BR8204352A (pt) Processo para recuperacao e purificacao de derivados de acidos fenoxibenzoicos
IT1188938B (it) Procedimento per la puricazione di acido ursodesossicolico
ATE91711T1 (de) Verfahren zur enzymatischen hydrolyse von alpha- aminoadipinyl-monoaminoverbindungen.
IT1125606B (it) Processo per la purificazione di gas di rifiuto contenenti gas nitrosi
BR7803244A (pt) Processo de purificacao e de desfluoracao de acido fosforico impuro
DK154760C (da) Fremgangsmaade til fremstilling af acemetacin
IT7826932A0 (it) Processo di depurazione biologica di acque usate.
IT1142607B (it) Processo per la preparazione di acidi dienoici
SU649700A1 (ru) Способ получени -кетоспиртов
IT1041828B (it) Processo per la depurazione biologica di acque di scarico

Legal Events

Date Code Title Description
8364 No opposition during term of opposition